Paid Clinical Trials in Branson, MO
As of August 2026, 30 paid clinical trials are recruiting in Branson, Missouri. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Branson offers studies at sites including Cox Cancer Center Branson for conditions such as Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Malignant Digestive System Neoplasm, Plasma Cell Myeloma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Branson
Trials by drug in Branson
Filter results
30 clinical trials
Family Communications After Genetic Testing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Mobile Health for Adherence in Breast Cancer Patients
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Top Research Study Locations in Branson
Researchers run research studies in Branson, MO at 1 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cox Cancer Center Branson | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Malignant Digestive System Neoplasm | 30 |
Active & Upcoming Studies in Branson (2026)
Recruiting trials in Branson grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Common conditions studied in Branson
- Malignant Solid Neoplasm (4 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- Malignant Digestive System Neoplasm (2 active studies)
- Plasma Cell Myeloma (2 active studies)
- RISS Stage I Plasma Cell Myeloma (2 active studies)
- RISS Stage II Plasma Cell Myeloma (2 active studies)
Leading research sponsors in Branson
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Branson?
There are approximately 30 recruiting clinical trials in Branson, Missouri listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Branson pay participants?
Most recruiting trials in Branson compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Branson?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Branson?
The most common conditions under active study in Branson include Malignant Solid Neoplasm (4), Anatomic Stage IV Breast Cancer AJCC v8 (2), Malignant Digestive System Neoplasm (2), Plasma Cell Myeloma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Branson?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Branson on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Branson?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Branson?
Recruiting research sites in Branson include Cox Cancer Center Branson, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Branson right now?
The largest active categories in Branson are Cancer & tumors (21). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.